AI주식인사이트AI Stock Insight
C

아리바이오랩

261780KOSDAQ자연과학 및 공학 연구개발업

43.3 / 100

Reference Date: 2026-06-10

Financial Score8.5 / 40
News Sentiment18.8 / 25
Momentum2.0 / 20
Disclosure14.0 / 15
AI Analysis: the high debt ratio poses financial risk, Revenue is on a declining trend. Plunged 15.8% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Chabaksin Research Institute is a biotech company specializing in the development of vaccines and immunotherapies using advanced technologies such as virus-like particles (VLP), liposomes, and immune checkpoint inhibitors (ICI). The company focuses on immunological research, antigen presentation, and apoptosis-related mechanisms to develop new drugs for infectious diseases and cancer.

Number of Employees

49people

Average Salary

63.4M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 62.704.0Point
PBR
5.91Industry Average 3.241.0Point

1.8x industry avg (risky)

ROE
-81.07Industry Average -32.093.5Point

2.5x industry avg (excellent)

Debt Ratio
14.65Industry Average 7.310.0Point

2.0x industry avg (risky)

Trend 2023~20250.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼15.6% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼52.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -39.4% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 75

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 2,605Won52-week high 5,70052-week low 2,480
1-month return0.0Point

1m -15.83% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

9 totalPositive 2Neutral 7Negative 0
  • Positive최대주주변경을수반하는주식담보제공계약체결2026-06-09
  • Neutral[기재정정]주요사항보고서(전환사채권발행결정)2026-06-05
  • Neutral증권발행결과(자율공시)2026-06-05
  • Neutral최대주주변경을수반하는주식담보제공계약해제ㆍ취소등2026-06-01
  • Positive[기재정정]주요사항보고서(유상증자결정)2026-05-29